Abstract 248P
Background
Children receiving palliative care face unique physical and psychosocial needs. Parents may turn to complementary medicines (CM); however, related studies are limited. This study examined the pattern of CM use among pediatric patients with cancer and non-cancer conditions receiving palliative care.
Methods
Between April 2021 and June 2022, parents of patients (<19 years old) receiving palliative care were recruited from 3 hospitals in Hong Kong. They completed a structured survey on sociodemographic data, CM use, and the child’s symptom burden (Rotterdam Symptoms Checklist). Clinical data were collected from health records. Differences in characteristics were compared among CM users (with cancer or non-cancer conditions) and non-users.
Results
We recruited 61 patients (60.7% male; mean age=10.4 years). Overall, 68.9% reported CM use, most commonly Chinese herbal medicine (39.3%) and massage/TuiNa (34.4%). Among the 24 patients with cancer, 62.5% were CM users; they were older at cancer diagnosis than non-users (p<0.001). Non-oral CM approaches, especially acupuncture, were less popular among patients with cancer than non-cancer patients (29.2% vs 64.9%, p=0.01). Among CM users, patients with cancer had higher physical symptom distress than non-cancer users (22.0 vs 17.3, p<0.01). More parents of children with cancer consulted their doctors before using CM than non-cancer users (73.3% vs 33.3% p=0.03), and considered CM to be effective in relieving nausea, vomiting and indigestion symptoms (p<0.05). Most parents (73%) spent ≥USD 130 on CM monthly. Among cancer patients, the most common reason for not using CM was the lack of information (55.6%). Multivariable analyses showed that older parents (aOR=1.15, 95%CI=1.02-1.31) were more likely to use CM, while children who received bone marrow transplant were less likely to use CM (aOR=0.16, 95%CI=0.03-0.73). Most parents (82.5%) supported CM integration, especially Chinese medicine and acupuncture, into palliative care service.
Conclusions
Two-third of surveyed pediatric patients with cancer receiving palliative care used CM regularly. Future work should explore integrating CM approaches into palliative programs for symptom management and psychological support.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
186P - Degradation of BRCA2 expression by hyperthermia sensitizes HRD-negative (BRCA2 wild-type) ovarian cancer cells to niraparib
Presenter: Junyang Li
Session: Poster viewing 03
187P - BUB1 (2530C>T) polymorphism and expression affects chemotherapy response and predicts poor prognosis in advanced epithelial ovarian cancer
Presenter: Sinjini Sarkar
Session: Poster viewing 03
188P - Spatial transcriptomic analysis of tumor tissue in ovarian cancer patients treated with neoadjuvant chemotherapy
Presenter: Irina Larionova
Session: Poster viewing 03
189P - LncRNA NKILA as a negative regulator of NFkB in ascites in ovarian cancer
Presenter: Dinara Dolgova
Session: Poster viewing 03
190P - Real-world applications of poly (ADP-ribose) polymerase inhibitors for ovarian cancer: A single-center study in China
Presenter: dengfeng wang
Session: Poster viewing 03
191P - Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
Presenter: N Thejeswar
Session: Poster viewing 03
192P - Human epididymis protein 4 as a predictor of response to neoadjuvant chemotherapy in epithelial ovarian cancer
Presenter: Sarada Planjery
Session: Poster viewing 03
193P - Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice: Experience of re-challenge mode of olaparib usage
Presenter: Alexander Sultanbaev
Session: Poster viewing 03
194P - A study of the treatment response of concomitant external beam radiotherapy (EBRT) and intracavitary brachytherapy in the management of locally advanced carcinoma of uterine cervix
Presenter: Asish Chowdhury
Session: Poster viewing 03
195P - Awareness of human papillomavirus (HPV) infection, cervical cancer (CC), and vaccine among females in Sultanate of Oman
Presenter: Abdulrahman Al-Mirza
Session: Poster viewing 03